Sherbrooke Park Advisers’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-19,690
Closed -$453K 683
2025
Q2
$453K Buy
19,690
+8,686
+79% +$201K 0.2% 205
2025
Q1
$247K Buy
+11,004
New +$256K 0.12% 363
2024
Q4
Sell
-16,831
Closed -$306K 1081
2024
Q3
$306K Buy
+16,831
New +$321K 0.07% 557
2024
Q2
Sell
-35,756
Closed -$700K 1150
2024
Q1
$700K Buy
+35,756
New +$755K 0.14% 246

Other funds holding PRVA

Sherbrooke Park Advisers's PRVA Position: Q3 2025 in Review

Sherbrooke Park Advisers sold out of Privia Health (PRVA) in Q3 2025, closing a stake of 19,690 shares — an estimated $453K sold.

Sherbrooke Park Advisers first reported a position in PRVA in Q1 2024 and held it in 4 quarters. The position peaked at $700K in Q1 2024. 259 funds tracked by Wall St. Rank hold PRVA as of Q3 2025.

  • Sherbrooke Park Advisers reported no remaining Privia Health position as of Q3 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 19,690 Privia Health shares in Q3 2025, an estimated $453K.
  • Sherbrooke Park Advisers first reported a position in Privia Health in Q1 2024 and held it in 4 quarters.
  • Sherbrooke Park Advisers's Privia Health position peaked at $700K in Q1 2024.
  • 259 funds tracked by Wall St. Rank held Privia Health as of Q3 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.